Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Oct. 31-Nov. 8. Deal Watch is supported by deal intelligence from Strategic Transactions.
In an amendment to their 2003 neuroscience R&D collaboration, Lexicon Pharmaceuticals Inc. and Bristol-Myers Squibb Co. have agreed...







